SAN DIEGO -- Biomarker and cognitive data supported treatment with the anti-amyloid agent lecanemab (Leqembi) for up to 36 ...
They then measured the concentrations of five molecular markers that previous research suggested might hold promise for diagnosing brain injuries: GFAP, neurofilament light chain, amyloid-beta 40 ...
The study was conducted decades after these injuries, with an average time gap of about 40 years between the last injury and ...
SOUND+THERAPY is a bedside device that uses 40 Hertz gamma sound beats and light flashes to promote better sleep. Studies suggest that gamma therapy may help reduce dementia-causing Amyloid beta ...